%PDF-1.4
%
1 0 obj
<>stream
iText 4.2.0 by 1T3XT2016-03-16T18:02:50+05:30Arbortext Advanced Print Publisher2020-01-30T08:19:17-08:002020-01-30T08:19:17-08:00uuid:8addd02c-2a8d-4824-a074-0375b52bef83uuid:9735c38c-787b-4f5b-aca7-e8422204bc96JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration© 2017 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases2167-84212167-9223001-31310.1080/21678421.2017.1373978https://doi.org/10.1080/21678421.2017.1373978application/pdf10.1080/21678421.2017.1373978en-USALSUntangled 42: Elysium health’s “basis”Informa UK Limited, trading as Taylor & Francis GroupAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2017. doi: 10.1080/21678421.2017.1373978VoR2017-09-18truewww.tandfonline.com10.1080/21678421.2017.1373978www.tandfonline.comtrue2017-09-1810.1080/21678421.2017.1373978
endstream
endobj
4 0 obj
<>stream
xYI5_?cJh"FP*^F=mk\`oꗧ'zUQG0* jp|)d}kcOx]e Ǯ*#7x2{;R3wz&(6.4N77LJFsѵ5t?9m&ć,iP^y1 ]I,xr7d*sgH71Eu=Cl0ƌ4zo:}>Vuxx;:xFA*RYPJRO
6H֯vjkP?<mǜ LCΫ;{|~UNs0L_,NThƑ:be|d/S!